MYC and cancer: Deregulated expression of MYC is recognized as the Achilles heel of many cancer types and hence is widely regarded to be a promising therapeutic target [8,9]; however, effective pharmacological MYC inhibitors are elusive, even leading to the conclusion that MYC might be ‘undruggable’ [24,25].